Xact Kapitalforvaltning’s Teva Pharmaceuticals TEVA Stock Holding History

Xact Kapitalforvaltning’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$258K	Sell	28,700 -10,400	-27%	-$107K	0.01%	1090
2019 Q4	$383K	Hold	39,100	–	–	0.01%	1129
2019 Q3	$269K	Hold	39,100	–	–	0.01%	1246
2019 Q2	$361K	Buy	39,100 +10,600	+37%	+$128K	0.01%	1118
2019 Q1	$447K	Buy	28,500 +1,800	+7%	+$31.7K	0.01%	988
2018 Q4	$412K	Buy	26,700 +10,500	+65%	+$215K	0.01%	1023
2018 Q3	$349K	Hold	16,200	–	–	0.01%	1259
2018 Q2	$394K	Buy	16,200 +1,700	+12%	+$34.7K	0.01%	1120
2018 Q1	$248K	Buy	14,500 +1,700	+13%	+$33.2K	0.01%	1366
2017 Q4	$243K	Buy	+12,800	New	+$193K	0.01%	1097
2017 Q3	–	Sell	-8,100	Closed	-$269K	–	630
2017 Q2	$269K	Buy	+8,100	New	+$251K	0.01%	635

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Xact Kapitalforvaltning's TEVA Position: Q1 2020 in Review

Xact Kapitalforvaltning reduced its Teva Pharmaceuticals (TEVA) stake by 27% in Q1 2020, selling an estimated $107K and leaving 28,700 shares worth $258K. The position accounts for 0.01% of the portfolio, ranked #1090.

Xact Kapitalforvaltning first reported a position in TEVA in Q2 2017 and has held it in 11 quarters since. The position peaked at $447K in Q1 2019. 460 funds tracked by Wall St. Rank hold TEVA as of Q1 2020.

Xact Kapitalforvaltning held 28,700 shares of Teva Pharmaceuticals worth $258K as of Q1 2020.
Xact Kapitalforvaltning sold 10,400 Teva Pharmaceuticals shares in Q1 2020, an estimated $107K.
Teva Pharmaceuticals made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1090 holding.
Xact Kapitalforvaltning first reported a position in Teva Pharmaceuticals in Q2 2017 and has held it in 11 quarters since.
Xact Kapitalforvaltning's Teva Pharmaceuticals position peaked at $447K in Q1 2019.
460 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.